Centrally acting agents for obesity: past, present, and future
Ditto for claims that peptides can help with focus, weight loss, energy, sleep, wrinkles, and more
Key Takeaways GLP-1 medicines mimic a natural gut hormone Most current options are injectable Oral GLP-1 medicines are emerging as a major advancement Newer oral options aim to improve ease and adherence Treatment choice depends on individual health needs GLP-1 medicines are changing how diabetes and obesity are managed
My experience with vitastir has been amazing
GLP-1RAs currently available on the market include semaglutide (sold as Ozempic and Rybelsus), liraglutide (Victoza), dulaglutide (Tulicity), exenatide ( Byetta and Bydureon ), and tirzepatide ( Mounjaro )